E-LIB Suche - Ergebnisse für: Lofland, J.

1

P715 Opioid use in patients with inflammatory bowel disease:

Lin, X ; Lofland, J ; Zhang, L...
Journal of Crohn's and Colitis. 12 (2018) supplement_1 - p. S473-S473 , 2018

Link: https://doi.org/10.1093/..

2

Shared decision making among Patients with autoimmune condi..:

Lofland, J. ; Johnson, P.T. ; Watkins, A..
Value in Health. 18 (2015) 3 - p. A301 , 2015

Link: https://doi.org/10.1016/..

3

Infliximab therapy adherence differences by site of care am..:

Khetia, A. ; Lofland, J. ; Olson, W....
Value in Health. 17 (2014) 3 - p. A39 , 2014

Link: https://doi.org/10.1016/..

4

Relative adherence across sites-of-care for infliximab pati..:

Michels, S. ; Ten Eyck, L. ; Vanderpoel, J....
Value in Health. 17 (2014) 3 - p. A39 , 2014

Link: https://doi.org/10.1016/..

5

Health care costs by level of adherence for infliximab pati..:

Michels, S. ; Ten Eyck, L. ; Vanderpoel, J....
Value in Health. 17 (2014) 3 - p. A39 , 2014

Link: https://doi.org/10.1016/..

6

Comparison of clinical and cost characteristics among patie..:

Vanderpoel, J. ; Schenkel, B. ; Lofland, J...
Value in Health. 16 (2013) 3 - p. A122 , 2013

Link: https://doi.org/10.1016/..

7

PSY58 Racial and Ethnic Differences in Patient Perceptions ..:

Bolge, S. ; Vanderpoel, J. ; Eldridge, H....
Value in Health. 15 (2012) 4 - p. A109 , 2012

Link: https://doi.org/10.1016/..

8

PSY24 Association of Patient Cost or Reimbursement Challeng..:

Vanderpoel, J. ; Lofland, J. ; Schenkel, B...
Value in Health. 15 (2012) 4 - p. A102-A103 , 2012

Link: https://doi.org/10.1016/..

9

Self-reported adherence, medication use, and switching patt..:

Howe, A ; Lofland, J ; Waters, H..
Inflammatory Bowel Diseases. 17 (2011) suppl_1 - p. S47-S47 , 2011

Link: https://doi.org/10.1093/..

10

Stability of infliximab dosing among individuals with Crohn..:

Lofland, J ; Vanderpoel, J ; Kassed, C...
Inflammatory Bowel Diseases. 17 (2011) - p. S38 , 2011

Link: https://doi.org/10.1097/..

11

PSY67 REASONS FOR INITIATING INTRAVENOUS BIOLOGIC THERAPY A..:

Bolge, S. ; Vanderpoel, J. ; Eldridge, H....
Value in Health. 14 (2011) 3 - p. A71 , 2011

Link: https://doi.org/10.1016/..

12

Cost-effectiveness of immunomodulators versus infliximab fo..:

Malone, D ; Hurwitz, J ; Lofland, J...
Inflammatory Bowel Diseases. 17 (2011) suppl_1 - p. S53-S54 , 2011

Link: https://doi.org/10.1093/..

13

Demographics, Comorbidities, and Biometric Characteristics ..:

Carter, C ; Lofland, J ; Ryan, A...
Inflammatory Bowel Diseases. 17 (2011) - p. S33 , 2011

Link: https://doi.org/10.1097/..

14

PSY25 RELATIONSHIP BETWEEN MONTHLY OUT-OF-POCKET HEALTHCARE..:

Naim, A. ; DiBonaventura, M. ; Lofland, J..
Value in Health. 14 (2011) 3 - p. A63 , 2011

Link: https://doi.org/10.1016/..

15

PSY62 PERCEIVED BENEFITS AND DISADVANTAGES OF INTRAVENOUS (..:

Bolge, S. ; Vanderpoel, J. ; Eldridge, H....
Value in Health. 14 (2011) 3 - p. A70 , 2011

Link: https://doi.org/10.1016/..